Santiago Arroyo
Director/Board Member at H. LUNDBECK A/S
Net worth: 878 280 $ as of 2024-04-29
Profile
Presently, Santiago Arroyo holds the position of Chief Medical Officer & Senior VP-Development at Momenta Pharmaceuticals, Inc. Dr. Arroyo is also on the board of H. Lundbeck A. Dr. Arroyo previously occupied the position of Chief Medical Officer-Biotherapeutics at Pfizer Inc., Chief Medical Officer at Boston Pharmaceuticals, Inc., Head-Neurosciences & Discovery Medicine at Bristol Myers Squibb Co., Head-Global Clinical Development at Eisai Co., Ltd., Associate Professor at Hospital Clínic de Barcelona and Associate Professor at The Medical College of Wisconsin, Inc. Santiago Arroyo received a doctorate from Universidad Autónoma de Madrid and a doctorate from the University of Barcelona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-05 | 39,000 ( 0.13% ) | 878 280 $ | 2024-04-29 |
Santiago Arroyo active positions
| Companies | Position | Start |
|---|---|---|
| H. LUNDBECK A/S | Director/Board Member | 2021-03-22 |
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 2023-03-30 |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Director/Board Member | 2023-05-01 |
Former positions of Santiago Arroyo
| Companies | Position | End |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 2022-11-12 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2017-04-30 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2015-09-30 |
| EISAI CO., LTD. | Corporate Officer/Principal | 2006-12-31 |
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Corporate Officer/Principal | 2002-12-31 |
Training of Santiago Arroyo
| Universidad Autónoma de Madrid | Doctorate Degree |
| University of Barcelona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| PFIZER, INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| Private companies | 4 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Health Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Santiago Arroyo
